Literature DB >> 15997367

Cost analysis of procedures related to the management of renal artery stenosis from various perspectives.

Debby van Helvoort-Postulart1, Carmen D Dirksen, Abraham A Kroon, Patricia J Nelemans, Peter W de Leeuw, Alfons G H Kessels, Jos M A van Engelshoven, M G Myriam Hunink.   

Abstract

To determine the costs associated with the diagnostic work-up and percutaneous revascularization of renal artery stenosis from various perspectives. A prospective multicenter comparative study was conducted between 1998 and 2001. A total of 402 hypertensive patients with suspected renal artery stenosis were included. Costs were assessed of computed tomography angiography (CTA), magnetic resonance angiography (MRA), digital subtraction angiography (DSA), and percutaneous revascularization. From the societal perspective, DSA was the most costly (euro 1,721) and CTA the least costly diagnostic technique (euro 424). CTA was the least costly imaging procedure irrespective of the perspective used. The societal costs associated with percutaneous renal artery revascularization ranged from euro 2,680 to euro 6,172. Overall the radiology department incurred the largest proportion of the total societal costs. For the management of renal artery stenosis, performing the analysis from different perspectives leads to the same conclusion concerning the least costly diagnostic imaging and revascularization procedure.

Entities:  

Mesh:

Year:  2005        PMID: 15997367     DOI: 10.1007/s00330-005-2821-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  19 in total

1.  Stent placement for renal arterial stenosis: where do we stand? A meta-analysis.

Authors:  T C Leertouwer; E J Gussenhoven; J L Bosch; B C van Jaarsveld; L C van Dijk; J Deinum; A J Man In 't Veld
Journal:  Radiology       Date:  2000-07       Impact factor: 11.105

2.  The friction cost method for measuring indirect costs of disease.

Authors:  M A Koopmanschap; F F Rutten; B M van Ineveld; L van Roijen
Journal:  J Health Econ       Date:  1995-06       Impact factor: 3.883

3.  Towards a new approach for estimating indirect costs of disease.

Authors:  M A Koopmanschap; B M van Ineveld
Journal:  Soc Sci Med       Date:  1992-05       Impact factor: 4.634

Review 4.  Comparative safety of high-osmolality and low-osmolality radiographic contrast agents. Report of a multidisciplinary working group.

Authors:  V Lawrence; W Matthai; S Hartmaier
Journal:  Invest Radiol       Date:  1992-01       Impact factor: 6.016

Review 5.  The indications and results of percutaneous transluminal angioplasty and stenting in renal artery stenosis.

Authors:  D D Kidney; L S Deutsch
Journal:  Semin Vasc Surg       Date:  1996-09       Impact factor: 1.000

6.  Magnetic resonance angiography in progressive renal failure: a technology assessment.

Authors:  W F Lawrence; T M Grist; P C Brazy; D G Fryback
Journal:  Am J Kidney Dis       Date:  1995-05       Impact factor: 8.860

7.  Trends in adverse events after IV administration of contrast media.

Authors:  S T Cochran; K Bomyea; J W Sayre
Journal:  AJR Am J Roentgenol       Date:  2001-06       Impact factor: 3.959

Review 8.  Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism--a critical review.

Authors:  M R Rudnick; J S Berns; R M Cohen; S Goldfarb
Journal:  Am J Kidney Dis       Date:  1994-10       Impact factor: 8.860

9.  Cost efficacy of the diagnosis and therapy of renovascular hypertension.

Authors:  M D Blaufox; M L Middleton; J Bongiovanni; B R Davis
Journal:  J Nucl Med       Date:  1996-01       Impact factor: 10.057

10.  Detection, evaluation, and treatment of renovascular hypertension. Final report. Working Group on Renovascular Hypertension.

Authors: 
Journal:  Arch Intern Med       Date:  1987-05
View more
  1 in total

1.  Dose comparison of single versus double dose in contrast-enhanced magnetic resonance angiography of the renal arteries: intra-individual cross-over blinded trial using Gd-DTPA.

Authors:  J T Heverhagen; C L Wright; P Schmalbrock; M V Knopp
Journal:  Eur Radiol       Date:  2008-07-25       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.